Clinical Trial Update: Minocycline in Neurocognitive Outcomes - Sickle Cell Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial from the University of Cincinnati is investigating whether minocycline can improve neurocognitive outcomes in sickle cell disease, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: University of Cincinnati | Conditions: Sickle Cell Disease, Cognitive Impairment | Phase 1 | Status: NOT_YET_RECRUITING